rdfs: label
ar
azb
be-tarask
bg
ca
cs
cy
da
dag
de
el
en
es
et
eu
fa
fi
fr
gl
gpe
he
hu
hy
id
it
ja
ko
nb
nl
nn
or
pl
pt
ro
ru
se
sh
sl
smn
sms
sr
sv
te
th
tr
uk
vi
wuu
zh
zh-hant
zh-tw
"Nalokson"@id
"Nalokson"@sh
"Nalokson"@tr
"Naloksoon"@et
"Naloxon"@da
"Naloxon"@de
"Naloxon"@ro
"Naloxona"@eu
"Naloxona"@gl
"Naloxone"@vi
"Naloxone"@dag
"nalocson"@cy
"nalokson"@nn
"nalokson"@pl
"nalokson"@sl
"nalokson"@smn
"naloksona"@se
"naloksoni"@fi
"naloksoon"@sms
"naloxon"@sv
"naloxon"@cs
"naloxon"@hu
"naloxon"@nb
"naloxon"@nl
"naloxona"@ca
"naloxona"@es
"naloxona"@pt
"naloxone"@en
"naloxone"@it
"naloxone"@fr
"naloxone"@gpe
"ναλοξόνη"@el
"Налоксон"@bg
"налоксон"@ru
"налоксон"@sr
"налоксон"@uk
"наляксон"@be-tarask
"Նալոքսոն"@hy
"נרקאן"@he
"نالوكسون"@ar
"نالوکسان"@azb
"نالوکسان"@fa
"ନାଲୋକ୍ସୋନ"@or
"నలోక్సోన్"@te
"นาล็อกโซน"@th
"ナロキソン"@ja
"納洛酮"@zh
"納洛酮"@zh-hant
"納洛酮"@zh-tw
"纳洛酮"@wuu
"날록손"@ko
skos: altLabel
cy
en
gpe
zh
"(-)-naloxone"@cy
"(-)-naloxone"@en
"(-)-naloxone"@gpe
"(−)-naloxone"@en
"(−)-naloxone"@gpe
"1-N-Allyl-14-hydroxynordihydromorphinone"@cy
"1-N-Allyl-14-hydroxynordihydromorphinone"@en
"1-N-Allyl-14-hydroxynordihydromorphinone"@gpe
"17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one"@cy
"17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one"@en
"17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one"@gpe
"17-allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one"@en
"17-allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one"@gpe
"Nalossone"@en
"Nalossone"@gpe
"Naloxona"@en
"Naloxona"@gpe
"Naloxone"@en
"Naloxone"@gpe
"Naloxonum"@en
"Naloxonum"@gpe
"Narcan®"@cy
"Narcan®"@en
"Narcan®"@gpe
"l-naloxone"@cy
"l-naloxone"@en
"l-naloxone"@gpe
"納絡酮"@zh
schema: description
af
an
ar
ary
ast
be-tarask
bn
ca
cs
da
de
de-ch
el
en
en-ca
en-gb
eo
es
eu
fa
fi
fr
gl
gpe
he
hu
hy
id
it
ja
ks
la
lb
lv
mk
ml
nb
nl
nn
oc
or
pl
pt
pt-br
ro
ru
sk
sq
sv
tr
uk
zh
zh-hant
zh-tw
"antidotum tegen opioïden"@nl
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"component quimic"@oc
"compositum chemicum"@la
"compost químic, antagonista dels receptors opioides"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"opioid receptor antagonist"@en
"opioid receptor antagonist"@gpe
"opioid reseptör antagonisti"@tr
"opioidreceptorantagonist med medicinsk användning som motgift vid opioidöverdoser eller som skydd mot viss icke-avsedd användning av opioidsubstitutionspreprat"@sv
"organische Verbindung, Antidot gegen Opioid-Vergiftungen"@de
"senyawa kimia"@id
"szintetikus vegyület"@hu
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"антидот при передозировках опиоидов, в первую очередь героина"@ru
"хемиско соединение"@mk
"хімічна сполука"@uk
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"داروی ضد مخدر"@fa
"مركب كيميائي"@ar
"مركب كيميائي"@ary
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ନାଲୋକ୍ସୋନ, ଅନ୍ୟ ନାମ ନାରକାନ ଏଲ ଔଷଧ ଯାହା ଓପିଓଏଡ ବା ଏହାର ଅତିମାତ୍ରାର ପ୍ରଭାବକୁ ଅକାମି କରିଦିଏ ।"@or
"രാസസംയുക്തം"@ml
"オピオイド拮抗薬の一つ"@ja
"鴉片受體拮抗劑"@zh
"鴉片受體拮抗劑"@zh-hant
"鴉片受體拮抗劑"@zh-tw
schema: dateModified
"2026-11-04T13:38:56+00:00"^^xsd:dateTime
schema: version
2564707422
wikibase: identifiers
52
wikibase: sitelinks
46
wikibase: statements
81
p: P10245
wd: statement/Q282902-6c913c83-499f-79df-378a-5c35d1994196
wd: statement/Q282902-f89db277-4c78-b437-3491-bf049d599fe9
p: P10283
wd: statement/Q282902-140B9A2B-AD19-4901-8583-364DD3B1BA13
p: P11089
wd: statement/Q282902-573FA23F-EA56-4919-8177-2BCA59C627E1
p: P11143
wd: statement/Q282902-271F86F2-8FF4-405D-A676-B4A6E1473A73
p: P11198
wd: statement/Q282902-EBC0209B-93D0-466D-8EF4-FCCB11EAD26E
p: P11199
wd: statement/Q282902-DD2B60C9-70A5-4BA0-B66B-C13C2C3771A3
p: P117
wd: statement/Q282902-b172fbca-43de-ffe3-b1c4-5b1cb1bbcf92
p: P12385
wd: statement/Q282902-4084831d-8804-459c-b8d4-600901351ad0
p: P129
wd: statement/Q282902-B48D0F19-5A82-4217-94D6-8B88E5947B12
p: P1296
wd: statement/Q282902-293C5EB7-C4D5-4E72-BFED-5E32D5537C79
p: P1579
wd: statement/Q282902-B962EB0C-29DB-4CE8-A56B-02ED3D3A061F
p: P1889
wd: statement/Q282902-940BC956-7EA2-4C49-A6D7-F366D73452DB
p: P2017
wd: statement/Q282902-69382D5D-772C-468A-B9F8-89AC05A66F78
p: P2057
wd: statement/Q282902-3930251E-7505-4646-AB3A-C46075E9DCB8
p: P2062
wd: statement/Q282902-E32542CE-662F-4C42-AE58-132872943299
p: P2067
wd: statement/Q282902-9384A9E9-873E-484F-8A0B-DD68ADEFB460
p: P2115
wd: statement/Q282902-E7ADC13B-D6D7-4ABB-A653-971F804EDF3F
p: P2175
wd: statement/Q282902-19fe50a0-4d5b-d65f-51fd-bfcd73058907
wd: statement/Q282902-B8693CD5-B567-484A-938D-03631716D218
wd: statement/Q282902-D5B88397-920F-462E-80D3-0E48A24C2BD4
p: P2275
wd: statement/Q282902-41311342-0811-48C9-9570-A3218AB9AD20
wd: statement/Q282902-8d007b11-46b2-027d-2ef2-ff62ae396594
p: P231
wd: statement/Q282902-36BAA613-D91F-44D4-BAE9-5C3565FEFB90
p: P232
wd: statement/Q282902-705F165C-D501-43DE-84C1-0E2C41C41ACF
p: P233
wd: statement/Q282902-B24666A1-EBAF-400D-AC32-B0E6EB93AA76
p: P234
wd: statement/Q282902-621F60AE-DC82-4EDD-85F8-3BE50BDB7156
p: P2347
wd: statement/Q282902-14B70FBE-D84D-40F8-B794-4A83C11B1354
p: P235
wd: statement/Q282902-A185E020-51A8-4D6E-9F81-23015A6724DB
p: P2566
wd: statement/Q282902-13572468-2468-1357-eca9-bdf024681357
p: P267
wd: statement/Q282902-662fb67c-4af2-2620-2f91-5c6b421eb223
wd: statement/Q282902-9DA76352-F321-44EE-8FAB-38BAAB136D32
p: P274
wd: statement/Q282902-D5DF0EB2-20F7-4360-A5BB-ECC6DACD2A6E
p: P279
wd: statement/Q282902-FBAA0AAC-B6C7-44D0-A0B0-97F161C007BD
p: P2840
wd: statement/Q282902-C8279FFA-2D0B-4764-A286-E1FE2BB0CF38
p: P2868
wd: statement/Q282902-221F20AB-CA1F-4972-A99C-BFE6ACD512D3
wd: statement/Q282902-3BA9BAF2-7B2D-46C3-950B-949772DF6089
wd: statement/Q282902-F410F563-6E6A-4584-92D2-D786269F9563
p: P2877
wd: statement/Q282902-3BCA8EE5-640E-41E9-A44F-72EAB5469EC6
p: P2892
wd: statement/Q282902-97A3A3C7-4533-4C7F-87CD-1071F40F029E
p: P31
wd: statement/Q282902-B19C00D1-AD44-47CE-911D-7FEA5D0CA05C
p: P3117
wd: statement/Q282902-99516848-E89D-4963-88EC-B72F4177EC8C
p: P3345
wd: statement/Q282902-C9E748BC-CEBA-44E3-8215-59EE097FB10E
p: P3350
wd: statement/Q282902-26839e26-44c5-242e-b474-41fad51e61dc
p: P3364
wd: statement/Q282902-512F0906-3F14-427B-BC13-98CA377A1138
wd: statement/Q282902-76AC50FC-B3A9-45B3-8AE5-EBD1C64341A6
p: P3417
wd: statement/Q282902-504EF9B8-9D9D-4B09-B5EC-0DB7EA14C346
p: P3489
wd: statement/Q282902-2E13DF97-5B8B-4D39-9BF0-122315297AC3
wd: statement/Q282902-4262B137-FA91-4BB7-BE5A-250817503A7E
p: P366
wd: statement/Q282902-F67135DD-DC3E-4BBA-A052-AC7CF744D441
p: P373
wd: statement/q282902-CF9896EB-4995-42DE-9F1D-A79AD740C44D
p: P3780
wd: statement/Q282902-48C78A9D-01A7-4A9B-BD8F-E55F4AB1F47E
wd: statement/Q282902-5BF3B145-4A2E-483A-8B0E-97A7835D113E
p: P4168
wd: statement/Q282902-2458AE57-6E27-4544-8042-099C981D8128
p: P4527
wd: statement/Q282902-A949E479-9521-4AD9-9A08-87285C5345C4
p: P486
wd: statement/Q282902-696D05A0-B329-401E-B323-4B76DF72FDFF
p: P5076
wd: statement/Q282902-0EF02369-2CD8-4417-BB48-5E7940D70076
p: P5806
wd: statement/Q282902-36F0B2E6-1B8E-4AB3-96F3-B1E858F42836
p: P592
wd: statement/Q282902-7331DD96-45F6-441E-8B97-103E6EAECEF0
p: P595
wd: statement/Q282902-9FE09422-B719-445B-A730-B4F916EEABA4
wd: statement/Q282902-D704E6BF-5F3F-4990-BCE7-DAF7A8B9B079
p: P636
wd: statement/Q282902-833e2803-4115-f2b4-ada7-18eebc233f96
wd: statement/Q282902-96ca40d3-4298-129d-9d07-8f668bd15c4a
wd: statement/Q282902-f2bc4d1f-47b7-7eee-8bd2-f32d3295cff0
p: P646
wd: statement/Q282902-F183482C-20FF-432D-BA67-26F2F280C7AD
p: P652
wd: statement/Q282902-67DA2061-C34A-4FF8-AE4D-93D36D9830B6
p: P661
wd: statement/Q282902-48411F81-1177-4B15-A020-12BD47FA5300
p: P662
wd: statement/Q282902-EA11BB5F-DFC4-47DC-A901-CB396C66CF55
p: P665
wd: statement/Q282902-43218E9D-F6C4-4FCA-BBE7-FF8DC51D9972
wd: statement/Q282902-8FE4E8FD-8A8E-4CE3-9326-7BA05FA07672
p: P6694
wd: statement/Q282902-35637fdd-403f-4403-5b35-a7bb1cb422a3
p: P672
wd: statement/Q282902-216f4817-4a10-dc7a-0422-4e4c830f62f0
wd: statement/Q282902-7dfa4a14-4a77-58fe-406f-cfa993b592b1
wd: statement/Q282902-862607b5-4605-985e-d928-5e9b4b2673a8
wd: statement/Q282902-fac226c2-4944-1962-2fd5-2fbdde65137f
p: P683
wd: statement/Q282902-0481C947-EE01-4DE7-B553-3A41BA45C023
p: P703
wd: statement/Q282902-116CD62C-E5E3-4B90-9A76-0FC86CF9162B
p: P715
wd: statement/Q282902-985E9805-A1B3-4AA6-9874-6DB652903C0F
p: P8494
wd: statement/Q282902-51A43BAC-4B0B-4DD3-A6A5-C1D3B55C9BA5
p: P8814
wd: statement/Q282902-FFFDCDF7-3E16-41AE-8C7E-F05F9C831A8C
p: P9635
wd: statement/Q282902-21AB9447-8854-45ED-994F-9F441685573C
p: direct-normalized/P2115
<http://purl.bioontology.org/ontology/NDFRT/N0000147938>
p: direct-normalized/P2347
<http://www.yso.fi/onto/yso/p25987>
p: direct-normalized/P4527
<http://data.parliament.uk/terms/429795>
p: direct-normalized/P486
<http://id.nlm.nih.gov/mesh/D009270>
p: direct-normalized/P5806
<http://snomed.info/id/372890007>
p: direct-normalized/P592
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL80>
p: direct-normalized/P661
<http://rdf.chemspider.com/4447644>
p: direct-normalized/P662
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596>
p: direct-normalized/P665
<http://www.kegg.jp/entry/C07252>
<http://www.kegg.jp/entry/D08249>
p: direct-normalized/P6694
<http://id.nlm.nih.gov/mesh/M0014441>
p: direct-normalized/P672
<http://id.nlm.nih.gov/mesh/D03.132.577.249.706>
<http://id.nlm.nih.gov/mesh/D03.605.497.750>
<http://id.nlm.nih.gov/mesh/D03.633.400.686.750>
<http://id.nlm.nih.gov/mesh/D04.615.723.795.706>
p: direct-normalized/P683
<http://purl.obolibrary.org/obo/CHEBI_7459>
p: direct-normalized/P8814
<http://wordnet-rdf.princeton.edu/rdf/id/03811921-n>
wdt: P10245
"a612022"
"a616003"
wdt: P10283
"C2908806481"
wdt: P11089
"342444"
wdt: P11143
"Naloxone"
wdt: P11198
"1878"
wdt: P11199
"PD009757"
wdt: P117
<http://commons.wikimedia.org/wiki/Special:FilePath/Naloxone.svg>
wdt: P12385
"naloxona"
wdt: P129
Opioid receptor, mu 1
wdt: P1296
"0125559"
wdt: P1579
"1089071"
wdt: P1889
naltrexone
wdt: P2017
"C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O"
wdt: P2057
"HMDB0015314"
wdt: P2062
"3279"
wdt: P2067
327.147^^xsd:decimal
wdt: P2115
"N0000147938"
wdt: P2175
opioid overdose
septic shock
opiate dependence
wdt: P2275
en
la
"naloxone"@en
"naloxonum"@la
wdt: P231
"465-65-6"
wdt: P232
"207-365-7"
wdt: P233
"C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O"
wdt: P234
"InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1"
wdt: P2347
"25987"
wdt: P235
"UZHSEJADLWPNLE-GRGSLBFTSA-N"
wdt: P2566
"100.006.697"
wdt: P267
"A06AH04"
"V03AB15"
wdt: P274
"C₁₉H₂₁NO₄"
wdt: P279
morphinan alkaloid
wdt: P2840
"70413"
wdt: P2868
antidote
WHO essential medicines
opioid antagonist
wdt: P2877
"34284"
wdt: P2892
"C0027358"
wdt: P31
type of chemical entity
wdt: P3117
"DTXSID8023349"
wdt: P3345
"7242"
wdt: P3350
"1526"
wdt: P3364
(+)-naloxone
(+)-Naloxone
wdt: P3417
"Naloxone"
wdt: P3489
US pregnancy category C
Australian pregnancy category B1
wdt: P366
medication
wdt: P373
"Naloxone"
wdt: P3780
Evzio
Narcan
wdt: P4168
"549277"
wdt: P4527
"429795"
wdt: P486
"D009270"
wdt: P5076
"RD-14-00157"
wdt: P5806
"372890007"
wdt: P592
"CHEMBL80"
wdt: P595
"1638"
"1676"
wdt: P636
subcutaneous injection
intramuscular injection
intravenous infusion and defusion
wdt: P646
"/m/011_yk"
wdt: P652
"36B82AMQ7N"
wdt: P661
"4447644"
wdt: P662
"5284596"
wdt: P665
"C07252"
"D08249"
wdt: P6694
"M0014441"
wdt: P672
"D03.132.577.249.706"
"D03.605.497.750"
"D03.633.400.686.750"
"D04.615.723.795.706"
wdt: P683
"7459"
wdt: P703
Papaver somniferum
wdt: P715
"DB01183"
wdt: P8494
"DTXCID703349"
wdt: P8814
"03811921-n"
wdt: P9635
"39"